Zobrazeno 1 - 10
of 4 118
pro vyhledávání: '"Severens, JL"'
Autor:
Williams P; Global Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.; Patient Centered Solutions, IQVIA, Courbevoie, France., Herring TA; Medical Evidence, Epidemiology, Vaccine & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, United States., Yokota RTC; P95, Epidemiology & Pharmacovigilance, Leuven, Belgium., Maia T; Patient Centered Solutions, IQVIA, Porto Salvo, Portugal., Venkatesan S; BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom., Marcus JC; Patient Centered Solutions, IQVIA, Washington, DC, United States., Settergren G; Global Evidence Portfolio Delivery, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Arnetorp S; Health Economic & Payer Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Lloyd A; Acaster Lloyd Consulting Ltd, London, United Kingdom., Severens JL; Severens HTA Consultancy, Venray, Netherlands., Varni JW; Texas A&M University, College Station, TX, United States., Dixon S; Patient representative, Sulphur Springs, TX, United States., Hamusankwa L; Patient representative, London, United Kingdom., Powell PA; Sheffield Centre for Health and Related Research (SCHARR), University of Sheffield, Sheffield, United Kingdom.; Philip A Powell Consulting, Sheffield, United Kingdom., Taylor S; Medical Evidence, Vaccine & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom., Ware JE Jr; John Ware Research Group, Watertown, ME, United States., Krol M; Patient Centered Solutions, IQVIA, Amsterdam, Netherlands.
Publikováno v:
JMIR research protocols [JMIR Res Protoc] 2024 Aug 13; Vol. 13, pp. e52643. Date of Electronic Publication: 2024 Aug 13.
Publikováno v:
Cancer Management and Research, Vol 2015, Iss default, Pp 279-289 (2015)
Olena Mandrik,1 Isaac Corro Ramos,2 Saskia Knies,1,3 Maiwenn Al,1,2 Johan L Severens1,2 1Institute of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands; 2Institute of Medical Technology Assessment (iMTA), Erasmus
Externí odkaz:
https://doaj.org/article/4e566a7339a847d8ae1d380f5135446e
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol 2015, Iss default, Pp 347-356 (2015)
Olena Mandrik,1 Saskia Knies,1,2 Johan L Severens1,3 1Institute of Health Policy and Management, Erasmus University, Rotterdam, 2National Health Care Institute, Diemen, 3iMTA Institute of Medical Technology Assessment, Erasmus University, Rotterdam,
Externí odkaz:
https://doaj.org/article/83bcbdef349849659b565fc143f7e163
Autor:
Gibson E; Wickenstones Ltd, Abingdon, UK., Ollendorf DA; Institute for Clinical Research and Health Policy Studies (ICRHPS), Center for the Evaluation of Value and Risk in Health (CEVR), Tufts Medical Center, Boston, MA, USA., Simoens S; Clinical Pharmacology and Pharmacotherapy, KU Leuven, Leuven, Belgium., Bloom DE; Harvard T.H. Chan School of Public Health, Boston, MA, USA., Martinón-Torres F; Department of Pediatrics, Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.; Genetics, Vaccines and Infections Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago, University of Santiago, Santiago de Compostela, Spain.; Centro de Investigación Biomédica En Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, España., Salisbury D; Royal Institute of International Affairs, Chatham House, London, UK., Severens JL; Severens HTA Consultancy, Venray, The Netherlands., Toumi M; InovIntell, Île-de-France, France., Molnar D; GSK, Wavre, Belgium., Meszaros K; GSK, Wavre, Belgium., Sohn WY; GSK, Philadelphia, MD, USA., Begum N; Freelance, C/O Gsk, Wavre, Belgium.
Publikováno v:
Journal of market access & health policy [J Mark Access Health Policy] 2023 Aug 10; Vol. 11 (1), pp. 2239557. Date of Electronic Publication: 2023 Aug 10 (Print Publication: 2023).
Autor:
Mandrik O, Severens JL, Doroshenko O, Pan'kiv V, Kravchun N, Vlasenko M, Hulchiy M, Baljuk M, Komisarenko Y, Martsynik E, Sokolova L, Zalis’ka O, Mankovsky B
Publikováno v:
Journal of Multidisciplinary Healthcare, Vol 2013, Iss default, Pp 249-257 (2013)
Olena Mandrik,1–3 Johan L Severens,1 Olena Doroshenko,4 Vladymir Pan'kiv,5 Nonna Kravchun,6 Maryna Vlasenko,7 Mykola Hulchiy,8 Maryna Baljuk,9 Yuliia Komisarenko,10 Eugene Martsynik,11 Liubov Sokolova,12 Olga Zalis'ka,2 Boris Mankovsky131Erasmus Un
Externí odkaz:
https://doaj.org/article/6f80475b5c4440a8a3bae313eabd0087
Autor:
Boonen A; Division of Rheumatology, Maastricht University Medical Centre+ Internal Medicine, Maastricht, The Netherlands a.boonen@mumc.nl.; Universiteit Maastricht Care and Public Health Research Institute, Maastricht, The Netherlands., Putrik P; Division of Rheumatology, Maastricht University Medical Centre+ Internal Medicine, Maastricht, The Netherlands.; Universiteit Maastricht Care and Public Health Research Institute, Maastricht, The Netherlands., Marques ML; Rheumatologist, Leiden University Medical Center, Leiden, The Netherlands.; Rheumatology, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal., Alunno A; Rheumatology Unit, University of Perugia Department of Medicine, Perugia, Italy., Abasolo L; Department of Rheumatology, Instituto de Investigation Sanitaria San Carlos, Hospital Clinico Universitario San Carlos, Madrid, Spain., Beaton D; Mobility Program Clinical Research Unit, St Michael's Hospital Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada., Betteridge N; Neil Betteridge Associates, London, UK., Bjørk M; Pain and Rehabilitation Center, and Department of Health, Medicine and Caring Sciences, Linköping University, Linkoping, Sweden., Boers M; Department of Epidemiology and Data Science; Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Amsterdam, The Netherlands., Boteva B; Patients with Arthritis and Rheumatism (PARE) working group, European League Against Rheumatism, Zurich, Switzerland., Fautrel B; PEPITES teams, Pierre Louis Institute for Epidemiology and Public Health, Inserm UMR 1136, Paris, France.; Rheumatology Dept, Pitié Salpetriere Hospital, Sorbonne University / Assistance Publique- Hôpitaux de Paris, Paris, Fance., Guillemin F; APEMAC, Université de Lorraine, Nancy, France.; CIC Epidémiologie Clinique, CHRU Nancy, Inserm, Université de Lorraine, Nancy, France., Mateus EF; Portuguese League Against Rheumatic Diseases (LPCDR) and Comprehensive Health Research Centre (CHRC), Lisbon, Portugal.; People with Arthritis and Rheumatism (PARE), European League Against Rheumatism, Zurich, Switzerland., Nikiphorou E; Centre for Rheumatic Diseases, King's College of London, London, UK.; Rheumatology Department, King's College Hospital, London, UK., Péntek M; Health Economics Research Center, University Research and Innovation Center, Óbuda University, Budapest, Hungary., Pimentel Santos F; Rheumatology Department, Centro Hospitalar de Lisboa Ocidental EPE Hospital de Egas Moniz, Lisboa, Portugal.; NOVA Medical School, Lisboa, Portugal., Severens JL; Erasmus School of Health Policy & Management and iMTA, Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands., Verstappen SMM; Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.; Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK., Walker-Bone K; MRC Versus Arthritis Centre for Musculoskeletal Health and Work, MRC Life course Epidemiology Unit, Southampton General Hospital, Southampton, UK., Wallman JK; Department of Clinical sciences, Lund University, Lund, Sweden.; Department of Rheumatology, Skåne University Hospital, Lund, Sweden., Ter Wee MM; Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Rheumatology and immunology, AI&I, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Westhovens R; Dept of Rheumatology, KU Leuven University Hospitals Leuven, Leuven, Belgium.; Skeletal Biology and Engineering Research Centre, KU Leuven Department of Development and Regeneration, Leuven, Belgium., Ramiro S; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.; Rheumatology, Zuyderland Medical Centre Heerlen, Heerlen, The Netherlands.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Sep; Vol. 80 (9), pp. 1116-1123. Date of Electronic Publication: 2021 Apr 08.
Autor:
Mandrik O; School of Health and Related Research, Health Economic and Decision Science (HEDS), The University of Sheffield, Sheffield, UK.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Section of Early Detection and Prevention, International Agency for Research on Cancer, Lyon, France., Tolma E; Faculty of Public Health, Kuwait University, Jabriya, Kuwait., Zielonke N; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Meheus F; Section of Early Detection and Prevention, International Agency for Research on Cancer, Lyon, France., Ordóñez-Reyes C; Centro Javeriano de Oncología, Hospital Universitario San Ignacio, Bogotá, Colombia., Severens JL; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.; Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, The Netherlands., Murillo R; Section of Early Detection and Prevention, International Agency for Research on Cancer, Lyon, France.; Centro Javeriano de Oncología, Hospital Universitario San Ignacio, Bogotá, Colombia.; Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.
Publikováno v:
Journal of medical screening [J Med Screen] 2021 Jun; Vol. 28 (2), pp. 70-79. Date of Electronic Publication: 2020 Jun 09.
Autor:
Bockting, Claudi1,2,3 (AUTHOR) c.l.bockting@amsterdamumc.nl, Bosmans, Guy4 (AUTHOR), Bergers, Nele1,4 (AUTHOR), Gavan, Luana1,4 (AUTHOR), Hiligsmann, Mickaël5 (AUTHOR), de Beurs, Derek6 (AUTHOR), Molenberghs, Geert7 (AUTHOR), Wijnen, Ben8 (AUTHOR), Lokkerbol, Joran9 (AUTHOR), van der Spek, Nadia1,3,10 (AUTHOR)
Publikováno v:
Trials. 10/16/2024, Vol. 25 Issue 1, p1-16. 16p.
Autor:
Schöner, Lukas1 (AUTHOR) Lukas.schoener@tu-berlin.de, Kuklinski, David2 (AUTHOR) david.kuklinski@unisg.ch, Wittich, Laura1 (AUTHOR), Steinbeck, Viktoria1 (AUTHOR), Langenberger, Benedikt1 (AUTHOR), Breitkreuz, Thorben3 (AUTHOR), Compes, Felix4 (AUTHOR), Kretzler, Mathias5 (AUTHOR), Marschall, Ursula6 (AUTHOR), Klauser, Wolfgang7 (AUTHOR), Citak, Mustafa8 (AUTHOR), Matziolis, Georg9 (AUTHOR), Schrednitzki, Daniel10 (AUTHOR), Grasböck, Kim11 (AUTHOR), Vogel, Justus2 (AUTHOR), Pross, Christoph1 (AUTHOR), Busse, Reinhard1 (AUTHOR), Geissler, Alexander2 (AUTHOR)
Publikováno v:
PLoS Medicine. 10/9/2024, Vol. 21 Issue 10, p1-23. 23p.
Autor:
Li, Tara1 (AUTHOR), Berdunov, Vladislav1 (AUTHOR) vlad.berdunov@putassoc.com, Hamilton, Robin2 (AUTHOR), Rojas, Yaneth Gil1 (AUTHOR), Bührer, Christian3 (AUTHOR), Cox, Oliver3 (AUTHOR), Postema, Roelien1 (AUTHOR), Bagijn, Marloes3 (AUTHOR)
Publikováno v:
Ophthalmology & Therapy. Oct2024, Vol. 13 Issue 10, p2577-2597. 21p.